Hepatitus-C Drugs Continuing to Escalate in Cost

(Source – PBS.org)

Spurred in part by recent estimates that $9 billion will be spent on Hepatitis-C drugs, the Department of Health and Human Services has scheduled a public forum to address rising drug costs. One of the objectives of this forum will be to focus on ways to enable recovery of drug research costs while maintaining relative affordability in the marketplace. Read an Associate Press news release by Ricardo Alonso-Zaldivar here.

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s 
 validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.